Is MRNA Overvalued?
Is MRNA (MRNA) overvalued right now? Technical analysis can't answer that question directly — valuation is fundamental. But we can show you where price sits relative to its own history and what our scanner's signals on MRNA have done lately.
Live snapshot: MRNA right now
MRNA current price: $49.06 (▲ +7.49% on the session).
Previous close: $45.64. Day range: $45.30 – $49.55.
Where MRNA sits historically
| 52-week range | $22.28 – $59.55 |
| All-time high | $497.49 |
| All-time low | $22.28 |
| % from 52w high | -17.6% |
| % from ATH | -90.1% |
Signal direction on MRNA
We haven't yet logged enough signals on MRNA to publish a symbol-specific win rate. The platform-wide 1h win rate runs around 52%; per-symbol numbers diverge once we have at least 30 signals logged.
What 'overvalued' usually means and doesn't
Technical analysis on MRNA is one input among many — not a forecast. Indicators (RSI, MACD, moving averages, volume) describe what's already happened. Useful for identifying probability-weighted setups; not for predicting tomorrow's price. Our published win rates show MRNA's actual signal accuracy — use those numbers as context, not promises.
How to actually evaluate MRNA
A simple framework for deciding on MRNA:
- Timeframe — Are you trading MRNA for hours, days, or months?
- Position size — How much capital are you willing to put at risk?
- Stop-loss — Where does the trade thesis become invalid?
- Profit target — Where do you take gains?
Once those four are set, the buy/sell decision becomes mechanical: take the trade if it fits the framework, skip it otherwise.